Skip to content
Application 212024
- Type
- ANDA
- Sponsor
- SPECGX LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LEVORPHANOL TARTRATE | LEVORPHANOL TARTRATE | TABLET;ORAL | 2MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0406-2224 | Levorphanol Tartrate | Levorphanol Tartrate | SpecGx LLC | ANDA | Current |
| 0406-2224 | Levorphanol Tartrate | Levorphanol Tartrate | SpecGx LLC | ANDA | Current |
| 0406-2224 | Levorphanol Tartrate | Levorphanol Tartrate | SpecGx LLC | ANDA | Current |
| 0406-2224 | Levorphanol Tartrate | Levorphanol Tartrate | SpecGx LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 76451 | ORIG | 2023-11-07 |